PROVIDER PROFILE · NPI 1326058777

Chloe AtreyaMD, PHD

Medical OncologySan Francisco, CAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

182

Unique beneficiaries

—

Total services

363

Distinct HCPCS

Medicare payment

$35K

Peer benchmark

Total Medicare services vs. 268 Medical Oncology providers in CA — below median (cohort median 1,130).

PRESCRIBING · PART D · 2024

Total Rx claims

125

Beneficiaries

—

Total drug cost

$526K

Distinct drugs

Brand share

44.8%

Top prescribed drugs

Trifluridine/Tipiracil Hcl43 claims

Sunitinib Malate25 claims

Prochlorperazine Maleate24 claims

Ondansetron Hcl20 claims

Apixaban13 claims

QUALITY · MIPS · 2024

Final MIPS score

87.0

Quality

86.8

Cost

70.5

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

0.51%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$3K

Payment records

By payment type

Consulting Fee$3K

Food and Beverage$274

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 050454

Hospital

REFERRAL NETWORK

Where Chloe Atreya's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 2 outbound destinations.

Receives referrals from

Inbound — who sends patients here

No inbound pairs above the suppression threshold.

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO	49	1,119
Karen Ordovas Diagnostic Radiology · Seattle, WA	11	27

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history